Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Gedian Humanwell Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of reproductive health medications and steroid hormones. As a core subsidiary of Humanwell Healthcare Group, the company is one of the largest production bases for emergency contraceptives and steroid active pharmaceutical ingredients (APIs) in China. Its product portfolio includes well-known brands like Postinor (levonorgestrel) and various treatments for central nervous system disorders and oncology. The company operates high-standard GMP manufacturing facilities and provides CDMO services for steroid-based APIs and finished dosage forms. Gedian Humanwell is recognized for its expertise in complex chemical synthesis and fermentation processes, distributing products to over 50 countries globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Gedian Humanwell Pharmaceuticals.